CERE - Cerevel Therapeutics Holdings Inc. (CERE) CEO Tony Coles on Q4 2020 Results - Earnings Call Transcript

Cerevel Therapeutics Holdings, Inc. (CERE) Q4 2020 Earnings Conference Call March 24, 2021 08:00 ET Company Participants Matt Calistri - Vice President, Investor Relations Tony Coles - Chief Executive Officer Ray Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Kathy Yi - Chief Financial Officer Conference Call Participants Paul Matteis - Stifel Michael Yee - Jefferies Greg Suvannavejh - Goldman Sachs Presentation Operator Good morning. Welcome to the Cerevel Therapeutics Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] Please note that this call maybe recorded. I will now hand the call over to Matt Calistri, Vice President of Investor Relations. Matt Calistri Thank you. Good morning, everyone. We appreciate you joining us for our fourth quarter and full year 2020 earnings call. On today’s call, you will be hearing from Dr. Tony Coles, our

For further details see:

Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q4 2020 Results - Earnings Call Transcript